Hepatic drug conjugation/deconjugation systems in hepatosplenic schistosomiasis.
Biochem Pharmacol
; 40(8): 1923-5, 1990 Oct 15.
Article
in En
| MEDLINE
| ID: mdl-2122898
The biotransformation capacity of the liver is altered in hepatosplenic schistosomiasis being more in favor of deconjugation pathways. These alterations should be considered when xenobiotics are administered and in studies of hepatic toxicity and carcinogenicity.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Schistosomiasis mansoni
/
Liver
Limits:
Animals
Language:
En
Journal:
Biochem Pharmacol
Year:
1990
Document type:
Article
Affiliation country:
Egypt
Country of publication:
United kingdom